Pyxis Oncology, Inc. (PYXS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 71.46M |
| Enterprise Value | 74.72M |
| P/E Ratio | -1.26 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 9.41 |
| Price/Book Ratio | 3.31 |
| Enterprise/Revenue | 10.64 |
| Enterprise/EBITDA | -1.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -7.86 |
| Operating Margin | -8.08 |
| Return On Assets | -1.13 |
| Return On Equity | -2.52 |
| Revenue | 13.86M |
| Revenue/Share | 0.13 |
| Gross Profit | 11.47M |
| EBITDA | -73.72M |
| Net Income | -79.62M |
| Diluted EPS | -1.28 |
| Total Cash | 55.57M |
| Total Cash/Share | 0.67 |
| Total Debt | 17.4M |
| Total Debt/Equity | 0.42 |
| Current Ratio | 2.96 |
| Book Value Per Share | 0.49 |
| 52-Week Change | -64.11 |
| 52-Week High | 5.55 |
| 52-Week Low | 1.03 |
| Moving Average 50 Days | 2.44 |
| Moving Average 200 Days | 2.16 |
| Average Volume | 1.02M |
| Shares Outstanding | 63.36M |
| % Held by Institutions | 53.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |